Delayed-type hypersensitivity response is a predictor of peripheral blood T-cell immunity after HER-2/neu peptide immunization.

Human neoplasms elicit multiple specific immune responses in the autologous host.

1995 • 1,097 citations

A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1994 • 934 citations

Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.

1999 • 339 citations

Correlation of specific immune responses with survival in melanoma patients with distant metastases receiving polyvalent melanoma cell vaccine.

1998 • 162 citations

HER-2/neu Oncogenic Protein: Issues in Vaccine Development

1998 • 80 citations

Immune response to polyvalent melanoma cell vaccine in AJCC stage III melanoma: An immunologic survival model

1996 • 59 citations

Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity

1983 • 45 citations